Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open-label, randomized controlled trial (BEYOND VII)
about
Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open-label, randomized controlled trial (BEYOND VII)
description
2020 nî lūn-bûn
@nan
2020年の論文
@ja
2020年学术文章
@wuu
2020年学术文章
@zh
2020年学术文章
@zh-cn
2020年学术文章
@zh-hans
2020年学术文章
@zh-my
2020年学术文章
@zh-sg
2020年學術文章
@yue
2020年學術文章
@zh-hant
name
Higher versus standard startin ...... controlled trial (BEYOND VII)
@en
type
label
Higher versus standard startin ...... controlled trial (BEYOND VII)
@en
prefLabel
Higher versus standard startin ...... controlled trial (BEYOND VII)
@en
P2093
P356
P1476
Higher versus standard startin ...... controlled trial (BEYOND VII)
@en
P2093
Alex Condoleon
Binhong Wen
Hailong Wan
Junfen Wang
Rongwen Bian
Wuyan Pang
P304
P356
10.1111/DOM.13967
P50
P577
2020-02-18T00:00:00Z